Zurcher Kantonalbank (Zurich Cantonalbank) Abb Vie Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Abb Vie Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 591,744 shares of ABBV stock, worth $115 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

591,744

Previous 501,366 18.03%

Holding current value

$115 Million

Previous $91.3 Million 11.17%

% of portfolio

0.34%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $14 Million - $16.3 Million	90,378 Added 18.03%	591,744 $101 Million
Q1 2024 Apr 25, 2024	BUY	$159.82 - $182.1 $15.1 Million - $17.2 Million	94,435 Added 23.21%	501,366 $91.3 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $36.3 Million - $40.8 Million	-263,502 Reduced 39.3%	406,931 $63.1 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $10.1 Million - $11.7 Million	-75,343 Reduced 10.1%	670,433 $99.9 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $65.5 Million - $81.5 Million	-494,172 Reduced 39.85%	745,776 $100 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $2.48 Million - $2.86 Million	17,165 Added 1.4%	1,239,948 $198 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $1.91 Million - $2.3 Million	13,845 Added 1.15%	1,222,783 $198 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $4.53 Million - $5.2 Million	33,777 Added 2.87%	1,208,938 $162 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $10.1 Million - $12.8 Million	73,390 Added 6.66%	1,175,161 $180 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $20 Million - $24.9 Million	151,879 Added 15.99%	1,101,771 $179 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $9,024 - $11,418	84 Added 0.01%	949,892 $129 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $4.37 Million - $4.96 Million	41,072 Added 4.52%	949,808 $102 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $1.75 Million - $1.95 Million	16,616 Added 1.86%	908,736 $102 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $33.3 Million - $36.7 Million	325,734 Added 57.51%	892,120 $96.5 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $3.6 Million - $4.85 Million	-44,667 Reduced 7.31%	566,386 $60.7 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $4.27 Million - $5.01 Million	49,701 Added 8.85%	611,053 $53.5 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $2.88 Million - $3.86 Million	-39,320 Reduced 6.55%	561,352 $55.1 Million
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $778,773 - $1.18 Million	-12,074 Reduced 1.97%	600,672 $45.8 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $13.1 Million - $16.4 Million	181,771 Added 42.18%	612,746 $54.3 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $1.44 Million - $1.73 Million	22,874 Added 5.6%	430,975 $32.6 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $395,514 - $505,559	-6,020 Reduced 1.45%	408,101 $29.7 Million
Q1 2019 Apr 29, 2019	BUY	$77.14 - $90.79 $4 Million - $4.71 Million	51,835 Added 14.31%	414,121 $33.4 Million
Q4 2018 Jan 25, 2019	SELL	$77.85 - $96.01 $4.58 Million - $5.65 Million	-58,882 Reduced 13.98%	362,286 $33.4 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $5.72 Million - $6.36 Million	-64,322 Reduced 13.25%	421,168 $39.8 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $5.24 Million - $6.2 Million	-58,333 Reduced 10.73%	485,490 $45 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $4.08 Million - $5.46 Million	-44,310 Reduced 7.53%	543,823 $51.5 Million
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $4.33 Million - $4.75 Million	48,334 Added 8.95%	588,133 $56.9 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $37.7 Million - $48.2 Million	539,799	539,799 $48 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Abb Vie Inc. Transaction History